Henry J. Fuchs, President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 10,000 shares at $80.12 ($801K) on 2018-04-02, disclosed to the SEC on 2018-04-03.
Seasonal sale ($801k) by President, Worldwide R&D — this insider has traded BMRN in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.12 | 3,350 | $268K | 33.5% |
| 2 | $80.12 | 6,650 | $533K | 66.5% |
| Total | $80.12 avg | 10,000 | $801K | 100% |
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |